21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34456877/
The 21-gene RS was related to favorable metabolic profiles including lower BMI, HOMA-IR, insulin, and C-peptide, and higher HDL in Chinese breast cancer patients, and its prognostic impact on breast...
-
Breast Cancer Connect4yrKey Points • Conclusion/Relevance: “The 21-gene RS [recurrence risk score] was related to favorable metabolic profiles including lower BMI, HOMA-IR, insulin, and C-peptide, and higher HDL in Chinese breast cancer patients, and Show More
Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34476341/
Over the brief interval examined, women with HR-positive breast cancer receiving OFS with an aromatase inhibitor experienced reductions in adenosine-associated changes in LV myocardial T1 relative to women who received...
The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34460112/
In August 2017, CDK4/6 inhibitors combined with endocrine therapy have been reimbursed in the Netherlands for patients with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer (ABC). This...
Multi- class classification of breast cancer abnormalities using Deep Convolutional Neural Network (CNN) - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34437623/
The real cause of breast cancer is very challenging to determine and therefore early detection of the disease is necessary for reducing the death rate due to risks of breast...
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34427465/
Background Suppression of background parenchymal enhancement (BPE) is commonly observed after neoadjuvant -chemotherapy (NAC) at contrast-enhanced breast MRI. It was hypothesized that nonsuppressed BPE may be associated with -inferior response...